- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06363448
Yamani Technique Versus Proline Mesh for Intraocular Lens Scleral Fixation in Aphakia
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Properly positioned posterior chamber IOL (PCIOL) offers many advantages over an anterior chamber IOL (ACIOL). The potential advantages of PCIOLs over ACIOLs include a reduction in the number of optical aberrations (e.g. magnification, aniseikonia, lens edge glare, flutter), a decreased incidence of secondary glaucoma, and free movement of the pupil to control the amount of light entering the eye.
The risk for corneal decompensation, secondary glaucoma, and cystoid macular edema may be less with PCIOLs than with ACIOLs. In the absence of capsular support, many techniques have been described to secure the haptics to the sulcus region.
All described techniques focus on IOL haptics fixation to the scleral wall at two or more points. These techniques are not free of complications, including IOL tilt, misalignment, myopic shift, IOL suture rupture, and dislocation. In a previous study, Othman et al compared classic ab-externo two-point IOL fixation with a new technique of IOL scleral fixation based on fashioning trans-scleral, a double rectangular suture sulcus reconstruction (DRSSR) to support the IOL optic, thus providing a cushion to the IOL being positioned in the sulcus.
Aim of
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Sohag, Egypt
- Elshimaa A.Mateen
-
Sohag, Egypt, 82511
- Ophthalmology department, Sohag University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- patients aged 40 years
- aphakic patients (post-traumatic or after complicated cataract surgery without capsular support).
Exclusion Criteria:
- Corneal decompensation.
- Jeopardized specular microscopy
- retinal or choroidal detachment
- retained Intraocular foreign body
- uveitis, Scleromalacia
- Reubeosis irides
- previous anti-glaucoma surgery.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Yamani technique
Yamani technique for aphakia
|
Patients were divided into two groups to undergo classic ab externo two-point scleral fixation or flanged haptics as described by Yamani or the 2*2 proline mesh technique.
|
|
Active Comparator: Proline mesh for aphakia
|
Patients were divided into two groups to undergo classic ab externo two-point scleral fixation or flanged haptics as described by Yamani or the 2*2 proline mesh technique.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Best corrected visual acuity (BCVA) in LogMAR
Time Frame: 6 months
|
Best corrected visual acuity (BCVA) in LogMAR
|
6 months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Elshimaa A.Mateen, Doctor, Assistant professor of ophthalmology, Sohag University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Soh-Med-24-3-04PD
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Aphakia, Postcataract
-
Beaver-Visitec International, Inc.CompletedEye Diseases | Cataract | Lens Opacities | Postcataract AphakiaUnited States
-
Beaver-Visitec International, Inc.CompletedEye Diseases | Cataract | Astigmatism | Lens Opacities | Postcataract Aphakia
-
Debbie S. Kuo, MDAlcon ResearchActive, not recruitingAphakia, PostcataractUnited States
-
Beaver-Visitec International, Inc.CompletedAphakia, Postcataract | Cataract; Eye DiseaseGermany, France, Spain
-
DAVID HAUSERUnknown
-
RxSight, Inc.Enrolling by invitation
-
Alcon ResearchRecruitingAphakiaPanama, Costa Rica, Dominican Republic, El Salvador
-
Medical University of ViennaRecruitingLens Luxation | IOL Subluxation | IOL Opacification | Aphakia - No Lens CapsuleAustria
-
Alcon ResearchNot yet recruiting
-
Cutting Edge SASRecruiting
Clinical Trials on Yamani Technique versus Prolene Mesh for Intraocular Lens Scleral Fixation in Aphakia
-
Military Institute od Medicine National Research...Recruiting